Exact Sciences Is Said to Be in Talks to Buy Genomic Health

(Bloomberg) -- Exact Sciences Corp. is in advanced talks to acquire Genomic Health Inc. for about $2.8 billion to bolster its cancer testing capabilities, people familiar with the matter said.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.